Related Experiment Video

Updated: Jul 11, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

Mortality reduction benefits of a comprehensive cardiac care program for patients with occlusive coronary artery

John A Merenich1, Kari L Olson, Thomas Delate

  • 1Department of Endocrinology, Colorado Permanente Medical Group, Denver, Colorado, USA. john.a.merenich@kp.org

Pharmacotherapy
|September 28, 2007
PubMed

Insights

Early enrollment in comprehensive cardiac care (CCC) programs significantly reduces mortality for coronary artery disease (CAD) patients. Prompt CCC intervention offers greater survival benefits, highlighting the importance of timely cardiac rehabilitation.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • Coronary artery disease (CAD) poses a significant global health burden, necessitating effective management strategies.
  • Comprehensive Cardiac Care (CCC) programs aim to improve outcomes for patients post-cardiac events.
  • The impact of timing for CCC program enrollment on long-term mortality in CAD patients remains an area for investigation.

Purpose of the Study:

  • To evaluate the effect of early versus delayed enrollment in a CCC program on all-cause mortality in patients with CAD.
  • To assess the association between the timing of CCC program initiation and survival rates following a coronary event.

Main Methods:

  • Retrospective, longitudinal cohort study utilizing the Kaiser Permanente Colorado tracking database.
  • Inclusion of 4896 patients with incident occlusive CAD events between January 1, 1996, and June 30, 2004.
  • Categorization into four cohorts based on CCC enrollment timing: early (<90 days), delayed (≥90 days), intermittent, and no CCC enrollment.

Main Results:

  • Patients with any CCC exposure demonstrated significantly lower mortality rates compared to the no CCC cohort (p<0.001).
  • Adjusted analyses revealed substantially reduced hazard rate ratios for all-cause mortality in early (0.11), delayed (0.35), and intermittent (0.54) CCC cohorts versus no CCC.
  • Early CCC enrollment (<90 days post-event) was associated with the greatest mortality reduction.

Conclusions:

  • Early and sustained enrollment in CCC programs significantly reduces all-cause mortality in CAD patients.
  • A strong inverse relationship exists between the timing of CCC program initiation and mortality risk.
  • Prompt initiation of comprehensive cardiac care following a coronary event is crucial for maximizing survival benefits.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...